Enlivex Therapeutics is blending biotech with blockchain. The clinical-stage company is deploying funds from its $212 million PE deal to build a crypto treasury
Related Posts
Worldcoin ‘disappointed’ with ban in Hong Kong, says authorities ‘overlooked’ aspects
The Worldcoin Foundation expressed disappointment with Hong Kong regulatory authorities’ recent ban, emphasizing its commitment to lawful operation…
Bitcoin eyes $100K? Hayes cites treasury buybacks, weak dollar as catalysts
Bitcoin surged past $87,700, fueled by a weakening US dollar and potential US Treasury buybacks. Arthur Hayes predicts…
Top analyst eyes new crypto, hinting a possible end to Binance Coin and Dogecoin reign
Binance token and Dogecoin dominance could come to an end amid recent price uncertainty. Investors are looking for…